GILD vs. HCA: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at GILD and HCA, comparing key factors like performance, valuation metrics, dividends, and financial strength.
Company Overview
GILD’s market capitalization of 139.38 billion USD is substantially larger than HCA’s 89.41 billion USD, indicating a significant difference in their market valuations.
HCA carries a higher beta at 1.50, indicating it’s more sensitive to market moves, while GILD (beta: 0.31) exhibits greater stability.
| Symbol | GILD | HCA |
|---|---|---|
| Company Name | Gilead Sciences, Inc. | HCA Healthcare, Inc. |
| Country | US | US |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Medical - Care Facilities |
| CEO | Mr. Daniel P. O'Day | Mr. Samuel N. Hazen |
| Price | 112.05 USD | 371.67 USD |
| Market Cap | 139.38 billion USD | 89.41 billion USD |
| Beta | 0.31 | 1.50 |
| Exchange | NASDAQ | NYSE |
| IPO Date | January 22, 1992 | March 10, 2011 |
| ADR | No | No |
Performance Comparison
This chart compares the performance of GILD and HCA over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
This section compares the market valuation of GILD and HCA. Key takeaways regarding their valuation, when viewed within their industry context, are presented in the commentary that follows.
- HCA’s Price-to-Book (P/B) ratio of -26.35 indicates a negative book value. This is a serious warning sign regarding its financial stability and raises critical questions about its solvency and overall financial health.
| Symbol | GILD | HCA |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 23.41 | 16.04 |
| Forward PEG Ratio (TTM) | 3.22 | 1.20 |
| Price-to-Sales Ratio (P/S, TTM) | 4.85 | 1.25 |
| Price-to-Book Ratio (P/B, TTM) | 7.29 | -26.35 |
| EV-to-EBITDA (TTM) | 14.78 | 9.58 |
| EV-to-Sales (TTM) | 5.44 | 1.88 |
Dividend Comparison
GILD’s dividend yield of 2.77% is notably higher than HCA’s 0.73%, suggesting a stronger emphasis on returning cash to shareholders.
| Symbol | GILD | HCA |
|---|---|---|
| Dividend Yield (TTM) | 2.77% | 0.73% |
Financial Strength Metrics Comparison
This section evaluates the financial strength of GILD and HCA. Noteworthy observations on their financial resilience, considered from an industry perspective, are detailed in the points that follow.
- HCA’s Debt-to-Equity (D/E) ratio of -13.20 indicates negative shareholder equity. This is a critical issue, signaling deep financial instability and potentially jeopardizing its ongoing operations and ability to secure credit.
| Symbol | GILD | HCA |
|---|---|---|
| Current Ratio (TTM) | 1.37 | 1.19 |
| Quick Ratio (TTM) | 1.23 | 1.06 |
| Debt-to-Equity Ratio (TTM) | 1.30 | -13.20 |
| Debt-to-Asset Ratio (TTM) | 0.44 | 0.78 |
| Net Debt-to-EBITDA Ratio (TTM) | 1.61 | 3.23 |
| Interest Coverage Ratio (TTM) | 8.35 | 5.17 |